GMM Pfaudler Q4 FY23 Consolidated PAT jumps to Rs. 38.47 Cr
The company has reported total income of Rs. 880.59 crores during the period ended March 31, 2023
The company has reported total income of Rs. 880.59 crores during the period ended March 31, 2023
The company has reported total income of Rs. 2188.08 crores during the period ended March 31, 2023
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development
The company has reported total income of Rs. 3928.8 crores during the period ended March 31, 2023
The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023
Anuh Pharma has reported total income of Rs. 158.34 crores during the period ended March 31, 2023
Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023
The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023
8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector
Subscribe To Our Newsletter & Stay Updated